For the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...

The therapy is also approved for treating advanced gastric cancer and relapsed or metastatic cervical cancer after ...

A clinical trial using engineered immune cells to hunt cancer cells has reported impressive results for solid tumours, a type ...

Phase 3 trial shows trastuzumab deruxtecan extends survival by over three months in advanced HER2-positive gastric cancer and ...

According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE: AZN) have released detailed Phase III results that could help position their ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...

Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major research shows.

HCG Manavata Cancer Centre has successfully performed its first Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC) ...

AstraZeneca reports major survival benefits in breast and gastric cancer trials with Enhertu, Imfinzi, and camizestrant at ...